254 related articles for article (PubMed ID: 23111110)
21. On the mechanism of accumulation of cholestanol in the brain of mice with a disruption of sterol 27-hydroxylase.
Båvner A; Shafaati M; Hansson M; Olin M; Shpitzen S; Meiner V; Leitersdorf E; Björkhem I
J Lipid Res; 2010 Sep; 51(9):2722-30. PubMed ID: 20511491
[TBL] [Abstract][Full Text] [Related]
22. On the mechanism of cerebral accumulation of cholestanol in patients with cerebrotendinous xanthomatosis.
Panzenboeck U; Andersson U; Hansson M; Sattler W; Meaney S; Björkhem I
J Lipid Res; 2007 May; 48(5):1167-74. PubMed ID: 17325385
[TBL] [Abstract][Full Text] [Related]
23. On the fluxes of side-chain oxidized oxysterols across blood-brain and blood-CSF barriers and origin of these steroids in CSF (Review).
Björkhem I; Leoni V; Svenningsson P
J Steroid Biochem Mol Biol; 2019 Apr; 188():86-89. PubMed ID: 30586624
[TBL] [Abstract][Full Text] [Related]
24. Evidence of cell damage induced by major components of a diet-compatible mixture of oxysterols in human colon cancer CaCo-2 cell line.
Biasi F; Chiarpotto E; Sottero B; Maina M; Mascia C; Guina T; Gamba P; Gargiulo S; Testa G; Leonarduzzi G; Poli G
Biochimie; 2013 Mar; 95(3):632-40. PubMed ID: 23092829
[TBL] [Abstract][Full Text] [Related]
25. Hydroxylation site-specific and production-dependent effects of endogenous oxysterols on cholesterol homeostasis: Implications for SREBP-2 and LXR.
Saito H; Tachiura W; Nishimura M; Shimizu M; Sato R; Yamauchi Y
J Biol Chem; 2023 Jan; 299(1):102733. PubMed ID: 36423680
[TBL] [Abstract][Full Text] [Related]
26. 24S-hydroxycholesterol in plasma: a marker of cholesterol turnover in neurodegenerative diseases.
Leoni V; Caccia C
Biochimie; 2013 Mar; 95(3):595-612. PubMed ID: 23041502
[TBL] [Abstract][Full Text] [Related]
27. Correlation between plasma levels of 7alpha-hydroxy-4-cholesten-3-one and cholesterol 7alpha-hydroxylation rates in vivo in hyperlipidemic patients.
Bertolotti M; Del Puppo M; Gabbi C; Corna F; Carulli L; Pellegrini E; Zambianchi L; Anzivino C; Ricchi M; Loria P; Kienle MG; Carulli N
Steroids; 2008 Oct; 73(11):1197-202. PubMed ID: 18582481
[TBL] [Abstract][Full Text] [Related]
28. Does brain specific 24S-hydroxycholesterol in plasma indicate the disruption of the blood-brain barrier in patients with ischemic stroke?
Holdenrieder S; Lütjohann D; Geiger S; von Bergmann K; Stieber P; Hamann GF
Neurosci Lett; 2004 Sep; 368(2):201-4. PubMed ID: 15351449
[TBL] [Abstract][Full Text] [Related]
29. ESI-MS/MS quantification of 7alpha-hydroxy-4-cholesten-3-one facilitates rapid, convenient diagnostic testing for cerebrotendinous xanthomatosis.
DeBarber AE; Connor WE; Pappu AS; Merkens LS; Steiner RD
Clin Chim Acta; 2010 Jan; 411(1-2):43-8. PubMed ID: 19808031
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the cytotoxic, pro-oxidant and pro-inflammatory characteristics of different oxysterols.
Lemaire-Ewing S; Prunet C; Montange T; Vejux A; Berthier A; Bessède G; Corcos L; Gambert P; Néel D; Lizard G
Cell Biol Toxicol; 2005 Mar; 21(2):97-114. PubMed ID: 16142584
[TBL] [Abstract][Full Text] [Related]
31. Oxysterols and neurodegenerative diseases.
Björkhem I; Cedazo-Minguez A; Leoni V; Meaney S
Mol Aspects Med; 2009 Jun; 30(3):171-9. PubMed ID: 19248803
[TBL] [Abstract][Full Text] [Related]
32. Are side-chain oxidized oxysterols regulators also in vivo?
Björkhem I
J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S213-8. PubMed ID: 18952574
[TBL] [Abstract][Full Text] [Related]
33. 7alpha-Hydroxylation and 3-dehydrogenation abolish the ability of 25-hydroxycholesterol and 27-hydroxycholesterol to induce apoptosis in thymocytes.
Zhang J; Xue Y; Jondal M; Sjövall J
Eur J Biochem; 1997 Jul; 247(1):129-35. PubMed ID: 9249018
[TBL] [Abstract][Full Text] [Related]
34. Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain.
Björkhem I
J Intern Med; 2006 Dec; 260(6):493-508. PubMed ID: 17116000
[TBL] [Abstract][Full Text] [Related]
35. Accumulation of 7 alpha-hydroxy-4-cholesten-3-one and cholesta-4,6-dien-3-one in patients with cerebrotendinous xanthomatosis: effect of treatment with chenodeoxycholic acid.
Björkhem I; Skrede S; Buchmann MS; East C; Grundy S
Hepatology; 1987; 7(2):266-71. PubMed ID: 3557306
[TBL] [Abstract][Full Text] [Related]
36. Oxysterol derivatives of cholesterol in neurodegenerative disorders.
Jeitner TM; Voloshyna I; Reiss AB
Curr Med Chem; 2011; 18(10):1515-25. PubMed ID: 21428891
[TBL] [Abstract][Full Text] [Related]
37. Oxysterols as markers of neurological disease--a review.
Leoni V
Scand J Clin Lab Invest; 2009; 69(1):22-5. PubMed ID: 19199127
[TBL] [Abstract][Full Text] [Related]
38. The Diagnostic Use of the Plasma Quantification of 24S-Hydroxycholesterol and Other Oxysterols in Neurodegenerative Disease.
Tripodi D; Vitarelli F; Spiti S; Leoni V
Adv Exp Med Biol; 2024; 1440():337-351. PubMed ID: 38036888
[TBL] [Abstract][Full Text] [Related]
39. Novel route for elimination of brain oxysterols across the blood-brain barrier: conversion into 7alpha-hydroxy-3-oxo-4-cholestenoic acid.
Meaney S; Heverin M; Panzenboeck U; Ekström L; Axelsson M; Andersson U; Diczfalusy U; Pikuleva I; Wahren J; Sattler W; Björkhem I
J Lipid Res; 2007 Apr; 48(4):944-51. PubMed ID: 17251592
[TBL] [Abstract][Full Text] [Related]
40. Sterol regulators of cholesterol homeostasis and beyond: the oxysterol hypothesis revisited and revised.
Gill S; Chow R; Brown AJ
Prog Lipid Res; 2008 Nov; 47(6):391-404. PubMed ID: 18502209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
